President Muhammadu Buhari has received the exploratory interactions, between Nigerian biomedical scientists and BioNTech company to support the production of messenger RNA vaccines in Nigeria. PM NEWS reports.
This is contained in a statement presented by Femi Adesina, Special Adviser to the President on Media & Publicity. Information Guide Nigeria
The President met with Mr Holm Keller, the Executive Chairman of KENUP Foundation and representative of the CEO of BioNTech, the mRNA vaccine patent holder, in Africa.
See Other Top News:
- 2023: Obi Has The Strength To Remove Nigeria Out Of Current Challenges – ADP Chieftain
- Senator Akpan Given 48 Hours to File Response in YPP Guber Case
- Nigerians ‘ll Be Free From Bondage If We Elect Peter Obi — Kenneth Okonkwo
- OPC Opposes Fuel Subsidy Removal
Buhari expressed confidence that the interactions between the parties would be productive, leading to collaborations at many levels, from clinical trials to research and development of new vaccines and eventually support vaccine manufacturing facilities in the country.
‘‘We are impressed with the numerous possibilities said to be around the mRNA technology and hence seek cooperation with well-intentioned organizations, including yours, to build a strong bilateral partnership with your company and your affiliate bodies, as science gets closer to understanding the possibilities around successful mRNA technology. jamb results
‘‘We believe the mRNA technology will help solve other public health challenges too, especially those peculiar to our tropical environment.
‘‘As you conduct exploratory interactions with our scientists in the biomedical field and officials of the Ministry of Health, I look forward to receiving a commitment to expand collaboration to achieve our goal of developing capacities for Research & Development and manufacturing.’’
‘‘KENUP Foundation will find in Nigeria, suitable research & development ecosystem, in terms of human resource expertise and endemic, deadly disease challenges that require research to help to end with new vaccines.
‘‘Our reputable scientific community has the capacity to engage with you meaningfully in all calibre of research and to add value to your joint effort.
‘‘Nigeria has a long tradition in vaccine manufacturing and laboratories for microbiological research, both in private and public facilities, and also for human and veterinary vaccine research, established over 80 years ago. You will find in Nigeria, biosafety Level 3 laboratories and ongoing initiatives with trusted partners to develop Level 4 capacity too.
‘‘We have a vibrant Health Ethics Research Council and our WHO Maturity Level 3 certified Regulatory body, National Agency for Food and Drug Administration and Control regulates vaccines, and have started the process to attain Maturity Level Four, that makes pharmaceutical products made in Nigeria, including vaccines, marketable abroad.
‘‘We invest significantly in health, education, in Research and Development and encourage discovery and partnership in joint ventures, such as with a private pharmaceutical company to begin routine vaccines manufacturing in-country.’’